These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8212636)

  • 1. [The hypertensive metabolic syndrome].
    Horký K
    Vnitr Lek; 1993 Sep; 39(9):836-43. PubMed ID: 8212636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical manifestations of the insulin resistance syndrome. The hormonal-metabolic syndrome X, the 5H syndrome and their etiopathogenesis].
    Hrnciar J
    Vnitr Lek; 1995 Feb; 41(2):92-8. PubMed ID: 7725646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The dilemma of syndrome X].
    Hrnciar J
    Vnitr Lek; 1992 Nov; 38(11):1041-4. PubMed ID: 1494865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance in hypertension--a relationship with consequences?
    Berne C
    J Intern Med Suppl; 1991; 735():65-73. PubMed ID: 2043224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insulin resistance and arterial hypertension].
    Hrnciarová M; Hrnciar J; Jakubíková K
    Vnitr Lek; 1995 Feb; 41(2):111-6. PubMed ID: 7725634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic disturbances and antihypertensive therapy.
    Mancini M; Ferrara AL; Strazzullo P; Marotta T
    J Hypertens Suppl; 1991 Dec; 9(3):S47-50. PubMed ID: 1798000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How should we implement the basic principles of treatment of type 2 diabetes mellitus from the aspect of the hormono-metabolic syndrome X (5H)?].
    Hrnciar J; Jakubíková K; Okapcová J
    Vnitr Lek; 1992 Aug; 38(8):729-37. PubMed ID: 1455753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic syndrome with vascular risk and arterial hypertension].
    Wassermann AO; Grosso CP
    Medicina (B Aires); 1996; 56(2):183-94. PubMed ID: 8935572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stress-induced hypertension and diabetes mellitus].
    Soucek M; Kára T
    Vnitr Lek; 2001 May; 47(5):315-9. PubMed ID: 11395876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperinsulinism as a major etiopathogenic link with arterial hypertension, hyperlipoproteinemia and hirsutism. II].
    Hrnciar J; Hrnciarová M; Jakubíková K; Okapcová J
    Vnitr Lek; 1992 May; 38(5):438-47. PubMed ID: 1509713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective imidazoline agonist moxonidine plus the ACE inhibitor ramipril in hypertensive patients with impaired insulin sensitivity: partners in a successful MARRIAGE?
    Rayner B
    Curr Med Res Opin; 2004 Mar; 20(3):359-67. PubMed ID: 15025845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [From type 2 diabetes to metabolic X syndrome].
    Pogátsa G
    Orv Hetil; 1999 Mar; 140(12):635-40. PubMed ID: 10217954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of insulin resistance in arterial hypertension.
    Sechi LA; Bartoli E
    Blood Press Suppl; 1996; 1():47-54. PubMed ID: 9162438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin resistance syndrome and hypertension].
    Shimamoto K
    Hokkaido Igaku Zasshi; 2000 Jan; 75(1):9-14. PubMed ID: 10736756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome].
    Hrnciar J
    Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relation between levels of leptin, insulin and cortisol in persons with the 5H (X) syndrome].
    Hrnciar J; Okapcová J; Lepej J; Gábor D
    Vnitr Lek; 1998 Feb; 44(2):68-75. PubMed ID: 9820079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
    Yamagishi S; Nakamura K; Takeuchi M
    Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.